Enhancing the Efficacy of Noncontact Laser Ablation of Weakly Absorbing Cholesteatoma Tissue Using a Blood Layer
Lasers in Surgery and Medicine · 2026-09 · 58 (7) · 541-549
DOI: 10.1002/lsm.70145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 15.05.2026. Verfasst von Paula Enzian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Laser Center Lübeck, Lübeck, Schleswig-Holstein, Germany. Hauptthemen laut MEDLINE: Laser Therapy, Lasers, Semiconductor, Cholesteatoma. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Federal Ministry of Research, Technology and Space.
Abstract (Originalsprache)
Objectives
The 445 nm diode lasers have already been used successfully and safely for cholesteatoma surgery. However, the ablation of low absorbing and strongly scattering anemic tissue, such as keratinizing squamous epithelium of the cholesteatoma becomes challenging with low laser power. The initiation of ablation often occurs abruptly and not reproducibly with a noticeable acceleration after the start of carbonization. This study investigates whether a thin layer of blood on an adequate tissue model can improve light absorption and ablation. Materials and Methods Porcine aortic tissue served as a model for pale, weakly absorbing tissue. Blood volumes of 2.5–110 μL were pipetted onto punch samples with a diameter of 12 mm. Tissue ablation was performed with a 445 nm diode laser at continuous wave powers of 1 W and 4 W at working distances of 1 mm and 2 mm to the distal tip of the transmitting multimode optical fiber, being moved with a speed of 5 mm/s across the tissue. Ablation depths and blood layer thicknesses were measured using optical coherence tomography (OCT). A theoretical model was used to estimate the optimal amount of blood to achieve the deepest ablation.
Results
Different blood layer thicknesses were examined, ranging from 17 μm to 1.3 mm. With the blood layer thickness of 50–100 μm the maximum ablation depth of approximately 370 μm was measured with a power of 4 W. Without blood, no ablation was achieved. However, it could be shown that the optimal blood layer thickness depended on the selected parameters, such as laser power and working distance. The experimental results closely matched model predictions, confirming the model's validity in estimating the ablation outcomes.
Conclusion
A thin blood layer enhances laser ablation of low‐absorbing tissue with 445 nm laser radiation, such as cholesteatoma, allowing precise tissue removal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Laser Center Lübeck, Lübeck, Schleswig-Holstein, Germany.
- Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Schleswig-Holstein, Lübeck, Schleswig-Holstein, Germany.
- Institute of Biomedical Optics, University of Lübeck, Lübeck, Schleswig-Holstein, Germany.
ORCID-Profile: Paula Enzian
Förderung
- Federal Ministry of Research, Technology and Space
Zitieren
APA
Enzian, P., Lühring, K., Lange, B., Leffers, D., Bruchhage, K. L., Leichtle, A., & Brinkmann, R. (2026). Enhancing the Efficacy of Noncontact Laser Ablation of Weakly Absorbing Cholesteatoma Tissue Using a Blood Layer. Lasers in Surgery and Medicine, 58(7), 541-549. https://doi.org/10.1002/lsm.70145
Vancouver
Enzian P, Lühring K, Lange B, Leffers D, Bruchhage KL, Leichtle A, et al. Enhancing the Efficacy of Noncontact Laser Ablation of Weakly Absorbing Cholesteatoma Tissue Using a Blood Layer. Lasers in Surgery and Medicine. 2026;58(7):541-549. doi:10.1002/lsm.70145
BibTeX
@article{Enzian2026,
author = {Enzian, Paula and Lühring, Kimberley and Lange, Birgit and Leffers, David and Bruchhage, Karl-Ludwig and Leichtle, Anke and Brinkmann, Ralf},
title = {Enhancing the Efficacy of Noncontact Laser Ablation of Weakly Absorbing Cholesteatoma Tissue Using a Blood Layer},
journal = {Lasers in Surgery and Medicine},
year = {2026},
volume = {58},
number = {7},
pages = {541--549},
doi = {10.1002/lsm.70145}
}
EUVIMED